As of 1:07pm ET
| +0.0357 / +2.95%|
The 1 analysts offering 12-month price forecasts for CASI Pharmaceuticals Inc have a median target of 3.00, with a high estimate of 3.00 and a low estimate of 3.00. The median estimate represents a +140.83% increase from the last price of 1.25.
The current consensus among 1 polled investment analysts is to Buy stock in CASI Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.